CPhI Worldwide 2019

Integrating the patient’s voice into drug delivery systems

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/Chinnapong)
(Image: Getty/Chinnapong)

Related tags: delivery, Drug delivery systems, Drug delivery, Drug delivery technologies, Drug delivery technology, Patient centricity, Insulin, Diabetes, West pharmaceutical services, West

While exhibiting its offering in self-administration devices at the CPhI Worldwide event in Frankfurt last week, West told us how patient convenience drives design and development.

In a time when the increasing prevalence of chronic diseases boosts the sales of self-administration devices​ and patient centricity has become one of the main topics of discussion​ across the various sectors of the industry, in-PharmaTechnologist spoke with Mike Schaefers, VP and GM for global pharma at West Pharmaceutical Services, about how the company is trying to answer current market needs.

“The challenge in the manufacture of self-administration devices comes as every patient is different, and every treatment, every new therapy that comes to market is different, and requires different administration,”​ Schaefers told us.

According to the executive, drug delivery methods are increasingly tailored around patients’ needs, and “[the] voice of the customer is now more than ever integrated in the development and optimization” ​of the devices.

Schaefers brought up the example of diabetes medication, which “half of the patients do not take, because they find it disturbing and painful. The current trend in the industry is ease of use and convenience,” ​he noted, adding that insurance companies also encourage this trend, by ‘demanding performance’.

Digitally-enabled devices ‘still in infancy’

Especially regarding diabetes, the company also looks to follow the ongoing industry trend that encourages developers to integrate digital technology​ to optimize dosage and biomarkers’ monitoring and, ultimately, disease management.

“Our devices offer opportunities to connect devices with smartphones, and we also develop applications that support this connection,” ​Schaefers noted.

However, the executive expressed the opinion that digitalization of care, in general, is ‘in its infancy’.

“I think we are still looking at solutions for all patients, even elderly patients who might not be so comfortable with digital technology. It is definitely a trend going forward, but it will take some time,”​ he said.

Related topics: Drug Delivery, Delivery technologies

Related news

Show more

Related products

show more

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Flow Cytometry Services

Flow Cytometry Services

Q2 Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Local lab Data Management

Local lab Data Management

Q2 Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Follow us

Products

View more

Webinars